HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

3rd Edition of International Heart Congress

June 05-07,2025 | Hybrid Event

June 05 -07, 2025 | Rome, Italy
Heart Congress 2025

Prescribing patterns and risk factor assessment in coronary artery disease patients undergoing angioplasty: A prospective study

Nilay Solanki, Speaker at Charotar University of Science and Technology
Charotar University of Science and Technology, India
Title : Prescribing patterns and risk factor assessment in coronary artery disease patients undergoing angioplasty: A prospective study

Abstract:

Background: Coronary artery disease (CAD) results from the obstruction of blood supply to the heart. Angioplasty is a common intervention for managing CAD, supplemented by supportive and preventive therapies. Modifiable risk factors for CAD include hypertension, diabetes, dyslipidemia, obesity, smoking, sedentary lifestyle, and type 2 traits, along with non-modifiable factors like age, gender, and family history. This study aimed to assess the risk factors associated with CAD and evaluate medication prescribing trends in CAD patients.

Methodology: A prospective analysis was conducted on 88 patients undergoing coronary angioplasty. Data on CAD risk factors and patients' medication history were collected and analyzed for prescribing patterns and rationality. Statistical analysis was performed using suitable tools.

Results: The majority of CAD patients were male (80.68%) with a mean age of 59.19 years, and most (39.77%) were aged between 61-70 years. Hypertension and diabetes were the most prevalent conditions at admission. Notably, BMI, stress, lack of exercise, hypertension, diabetes, and a family history of cardiovascular disease were identified as significant CAD risk factors (p<0.05). Commonly prescribed drugs included antiplatelets, antibiotics, antihypertensives, antiulcer medications, antihyperlipidemic, and antidiabetic agents. Drug interactions were detected in 19.31% of cases, with two classified as severe. Everolimus- and sirolimus-coated stents were frequently used.

Conclusion: In conclusion, a history of cardiovascular disease, hypertension, and diabetes emerged as major CAD risk factors. The study also highlighted some irrational prescribing trends. Enhanced patient counseling and care could help mitigate CAD risks and reduce the overall healthcare burden.

Biography:

Dr. Nilay Solanki is an Associate Professor at Ramanbhai Patel College of Pharmacy, CHARUSAT, India, with over 17 years of expertise in Pharmaceutical Sciences and Pharmacology. His research focuses on preclinical and clinical studies related to diabetes, cancer, neurodegeneration, etc. He collaborates with multispecialty hospitals for clinical research and has published over 50 papers in high-impact journals. Dr. Solanki has received numerous awards and has served as a resource person at national and international conferences. He is also an editor and reviewer for reputed journals and has completed various consultancy projects.

Watsapp